Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)

NCT06143748 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Esophagus Cancer

Interventions

DRUG: Cadonilimab
DRUG: Paclitaxel and cisplatin
RADIATION: intensity-modulated radiotherapy

Sponsor

Sun Yat-sen University